1. Home
  2. KLXE vs XLO Comparison

KLXE vs XLO Comparison

Compare KLXE & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • XLO
  • Stock Information
  • Founded
  • KLXE 2018
  • XLO 2016
  • Country
  • KLXE United States
  • XLO United States
  • Employees
  • KLXE N/A
  • XLO N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • XLO Health Care
  • Exchange
  • KLXE Nasdaq
  • XLO Nasdaq
  • Market Cap
  • KLXE 35.8M
  • XLO 42.2M
  • IPO Year
  • KLXE N/A
  • XLO 2021
  • Fundamental
  • Price
  • KLXE $1.97
  • XLO $0.70
  • Analyst Decision
  • KLXE Hold
  • XLO Buy
  • Analyst Count
  • KLXE 1
  • XLO 1
  • Target Price
  • KLXE $4.50
  • XLO $4.00
  • AVG Volume (30 Days)
  • KLXE 126.9K
  • XLO 3.3M
  • Earning Date
  • KLXE 08-06-2025
  • XLO 05-08-2025
  • Dividend Yield
  • KLXE N/A
  • XLO N/A
  • EPS Growth
  • KLXE N/A
  • XLO N/A
  • EPS
  • KLXE N/A
  • XLO N/A
  • Revenue
  • KLXE $688,600,000.00
  • XLO $9,274,000.00
  • Revenue This Year
  • KLXE N/A
  • XLO $300.08
  • Revenue Next Year
  • KLXE $3.97
  • XLO $1.87
  • P/E Ratio
  • KLXE N/A
  • XLO N/A
  • Revenue Growth
  • KLXE N/A
  • XLO N/A
  • 52 Week Low
  • KLXE $1.51
  • XLO $0.62
  • 52 Week High
  • KLXE $7.66
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 48.57
  • XLO 43.46
  • Support Level
  • KLXE $1.79
  • XLO $0.64
  • Resistance Level
  • KLXE $1.95
  • XLO $1.15
  • Average True Range (ATR)
  • KLXE 0.15
  • XLO 0.07
  • MACD
  • KLXE 0.02
  • XLO -0.03
  • Stochastic Oscillator
  • KLXE 51.85
  • XLO 10.75

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: